# Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke

> **NCT07369999** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 1062 (estimated)

## Conditions studied

- Mild Disabling Acute Ischemic Stroke

## Interventions

- **DRUG:** Combination Group
- **DRUG:** Control Group

## Key facts

- **NCT ID:** NCT07369999
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-06-30
- **Target enrollment:** 1062 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07369999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07369999, "Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07369999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*